Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Valar Labs
Valar Labs Announces Strategic Partnership with PathNet Lab to Deliver AI-Driven Bladder Cancer Insights Nationwide
December 22, 2025
From
Valar Labs
Via
Business Wire
Acupath and Valar Labs Announce Strategic Partnership to Deliver Vesta, AI-Powered Diagnostic Tests for Non–Muscle Invasive Bladder Cancer
December 03, 2025
From
Valar Labs
Via
Business Wire
Valar Labs’ CHAI Biomarkers Validated in New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
June 13, 2025
From
Valar Labs
Via
Business Wire
Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers
May 30, 2024
From
Valar Labs
Via
Business Wire
Valar Labs Announces Validation of First Histology-based Test to Predict Response to BCG in Bladder Cancer
May 01, 2024
From
Valar Labs
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.